Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Randomized Study of INCB161734 Plus Standard Chemotherapy Drug Combination in Untreated KRAS G12D Metastatic Pancreatic Ductal Adenocarcinoma Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium Denmark Finland France Germany +6
  • Molecularly Tailored Therapy Versus Standard Care in Patients With Advanced Pancreatic Cancer Using Olaparib, Erlotinib, Crizotinib, Trametinib, Pemigatinib, Selpercatinib, Axitinib, Vismodegib, Pembrolizumab, Larotrectinib, Dabrafenib, Capecitabine, Oxaliplatin, Fluorouracil, Irinotecan, Gemcitabine, Paclitaxel Albumin-Bound, and Calcium Folinate

    Not yet recruiting

    2 1 1 1
    Denmark
  • A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria France Germany Italy Poland +2
  • Study of M9140 for Patients With Advanced Pancreatic Cancer

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Austria France Germany Italy Spain
  • Study on Chemotherapy with Liposomal Irinotecan, Oxaliplatin, and 5-Fluorouracil for Patients with Pancreatic Cancer Spread to the Liver

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study of Irinotecan with S1 or 5-Fluorouracil for Patients with Metastatic Pancreatic Cancer After Gemcitabine Treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Austria Italy The Netherlands Spain
  • Study on Napabucasin, Paclitaxel, and Gemcitabine for Patients with Metastatic Pancreatic Cancer After Chemotherapy Failure

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    France Spain
  • Study on Dostarlimab, Vitamin D3, and Drug Combination for Untreated Metastatic Pancreatic Cancer Patients

    Not recruiting

    2 1 1 1
    France
  • Study on Durvalumab and Rintatolimod for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on the Safety and Effectiveness of IMM-101 with Radiotherapy for Patients with Limited Metastatic Pancreatic Cancer

    Not recruiting

    1 1 1
    Investigated Diseases:
    The Netherlands